TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01339923

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rMenB + OMV NZ vaccine
Description: 2 doses 2 months apart

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Meningococcal C oligosaccharide conjugated vaccine
Description: Schedule 3, 5, 7, 12, Meningococcal C oligosaccharide conjugated vaccine

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Meningococcal C oligosaccharide conjugated vaccine
Description: Schedule 3, 5, 7, 12, Meningococcal C oligosaccharide conjugated vaccine

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pneumococcal polysaccharide conjugate vaccine, 10 valent adsorbed.
Description: Schedule 3, 5, 7, 12 Pneumococcal polysaccharide conjugate vaccine, 10 valent adsorbed.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pneumococcal polysaccharide conjugate vaccine, 10 valent adsorbed.
Description: Schedule 3, 5, 7, 12 Pneumococcal polysaccharide conjugate vaccine, 10 valent adsorbed.
Study: NCT01920282

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nebivolol plus Lifestyle Modification
Study: NCT01339923

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rMenB + OMV NZ vaccine
Description: Schedule 3, 5, 12 rMenB + OMV vaccine

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rMenB + OMV NZ vaccine
Description: Schedule 13,15 rMenB + OMV vaccine
Study: NCT01163968

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MOMENTUM
Description: The Maximizing Outcomes Needed After Percutaneous Coronary Intervention (PCI) Using Weight Management (MOMENTUM) intervention is comprised of 6 modules, totaling 52 daily sessions promoting weight reduction, and 4 coaching sessions over the duration of the 12 week MOMENTUM intervention. The MOMENTUM intervention will be delivered using telehealth methods (Viterion telehealth device will be used to deliver the module content and coaching sessions). The intervention was purposively designed to overcome access barriers by using delivery modes accessible to patients in rural settings, in their home and at times convenient to their schedule.
Study: NCT03040804

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Low dose Radiotherapy
Description: Subjects in this protocol will only receive radiotherapy directed at one region, typically the region that is most bothersome to the patient. Patients will receive a total radiotherapy dose 7.5 Gy in five daily fractions of 1.5 Gy.
Study: NCT00459290

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mifepristone
Study: NCT01017523

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telephone support and behavior change
Description: Diabetes self-management education provided over the telephone either for individual or couples

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Telephone support and behavior change
Description: Diabetes self-management education provided over the telephone either for individual or couples

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Diabetes self-management education
Description: Limited diabetes self-management education provided over the telephone, serves as an enhanced usual care control intervention
Study: NCT03718520

Intervention type: OTHER
Intervention: no intervention, this is a purely observational study
Description: No intervention

Intervention type: OTHER
Intervention: no intervention, this is a purely observational study
Description: No intervention
Study: NCT01993901

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CSRT led telephone follow up
Description: Patients in the intervention group will be telephoned by the CSRT 4-6 weeks after completion of their treatment to assess any symptoms. A second follow up telephone call will be made at 12 weeks post treatment if required in order to address treatment related side effects that were identified during the first call and any interventions that were recommended
Study: NCT03164278

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Independent Transfer Training
Description: Independent Transfer Training Program: ITTP training starts with an overview and self-evaluation using the transfer assessment instrument questionnaire (TAI-Q) followed by three core modules: wheelchair setup, body setup, and flight/landing. Wheelchair setup includes factors such as the angle and distance of the wheelchair to the transfer surface, removing barriers, applying the brakes, and height of the transfer. Body setup involves positioning one's body for an optimal transfer and covers foot, hip, arm and hand positions. Flight/landing discusses how to achieve a smooth and controlled transfer, the head-hips relationship, use of transfer device, and safe landing.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Independent Transfer Training
Description: Independent Transfer Training Program: ITTP training starts with an overview and self-evaluation using the transfer assessment instrument questionnaire (TAI-Q) followed by three core modules: wheelchair setup, body setup, and flight/landing. Wheelchair setup includes factors such as the angle and distance of the wheelchair to the transfer surface, removing barriers, applying the brakes, and height of the transfer. Body setup involves positioning one's body for an optimal transfer and covers foot, hip, arm and hand positions. Flight/landing discusses how to achieve a smooth and controlled transfer, the head-hips relationship, use of transfer device, and safe landing.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Independent Transfer Training
Description: Independent Transfer Training Program: ITTP training starts with an overview and self-evaluation using the transfer assessment instrument questionnaire (TAI-Q) followed by three core modules: wheelchair setup, body setup, and flight/landing. Wheelchair setup includes factors such as the angle and distance of the wheelchair to the transfer surface, removing barriers, applying the brakes, and height of the transfer. Body setup involves positioning one's body for an optimal transfer and covers foot, hip, arm and hand positions. Flight/landing discusses how to achieve a smooth and controlled transfer, the head-hips relationship, use of transfer device, and safe landing.
Study: NCT04098393

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Fludarabine (25mg/m2/ day) administered on days -6, -5, -4, -3, and -2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Fludarabine (25mg/m2/ day) administered on days -6, -5, -4, -3, and -2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melphalan
Description: Melphalan (70mg/m2/day) administered on days -6 and -5.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melphalan
Description: Melphalan (70mg/m2/day) administered on days -6 and -5.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antithymocyte globulin (ATG)
Description: ATG will be given based on a dynamic nomogram based on the patient's absolute lymphocyte count at the start of conditioning and can result in 2 or 3 days of ATG administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antithymocyte globulin (ATG)
Description: ATG will be given based on a dynamic nomogram based on the patient's absolute lymphocyte count at the start of conditioning and can result in 2 or 3 days of ATG administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Busulfan 0.8 mg/kg
Description: Busulfan 0.8 mg/kg every 6 hours x 10 doses, with dose adjustments made according to PK levels.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Allogeneic hematopoietic cell transplantation (Allo-HCT)
Description: Allogeneic hematopoietic cell transplantation following the conditioning regimen.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Allogeneic hematopoietic cell transplantation (Allo-HCT)
Description: Allogeneic hematopoietic cell transplantation following the conditioning regimen.
Study: NCT02775175

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Modified Ramadan Fasting
Description: The intervention aims to provide knowledge about fasting and its effects on the body/mind, and health advice around nutrition to support health and well-being of participants during Ramadan.
Study: NCT00314548

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PGE1 (prostacyclin)
Description: alprostadil nebulization

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: nebulize for 30 mins
Study: NCT00089141

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: mycophenolate mofetil
Description: Given orally

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Given orally
Study: NCT01256853

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MVA Vaccine
Description: The starting dose will be 5 x 107 plaque forming units (pfu) given by intradermal vaccination. Cohorts of three patients will receive escalating doses of the vaccine (100%, 100%, 67% and 50%). The dose escalation scheme is 5 x 107 pfu, 1 x 108 pfu, 2 x 108 pfu, 3.3 x 108 pfu, 5 x 108pfu. This will be dependant on toxicity.
Study: NCT03418116

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Argus II Retinal Prosthesis
Description: The Argus II System is designed to provide visual function to individuals with severe to profound vision loss due to outer retinal degeneration. It consists of implanted and external components. The implant is an epiretinal prosthesis that is surgically implanted in and around the eye. The external equipment includes glasses and a video processing unit (VPU). The glasses include a miniature video camera, which captures video images, and a coil that sends data and stimulation commands to the implant. The VPU converts the video images into stimulation commands and is body-worn. The Argus II System operates by converting video images into electrical energy that activates retinal cells, delivering the signal through the optic nerve to the brain where it is perceived as light.
Study: NCT02780232

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cuida tu animo / Care for your mood
Description: CUIDA TU ÁNIMO is an online program to adolescents that provides information, education and support related to the care of the mood.~Adolescents interact with the program via a monitoring e-mail that they receive every two weeks (Monitoring) and a website which allows them to access a number of links. The website have the following modules:~1. What is 'CUIDA TU ÁNIMO': Description and definition of the program~2. Psycho-educational information: Information about depression, its treatment, and opportunities for prevention~3. How is your mood? (Monitoring): a) Online assessment of symptoms every two weeks during three months with the PHQ-3. b) Feedback~4. Forums.~5. Blog.~6. Appointment (Chat or Phone call).~7. Contact.
Study: NCT01222169

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: NaCl 0,9%
Description: Propofol 3micrgr/ml (TCI plasma concentration) and NaCl 0,9% 2min. and 10min. application

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NaCl 0,9%
Description: Propofol 3micrgr/ml (TCI plasma concentration) and NaCl 0,9% 2min. and 10min. application
Study: NCT00440869

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Description: 600 mg po bid

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: bid oral dosing
Study: NCT04646239

Intervention type: DIAGNOSTIC_TEST
Intervention: Heterologous stimuli
Description: In vitro exposure of peripheral blood mononuclear cells to heterologous stimuli

Intervention type: DIAGNOSTIC_TEST
Intervention: Neutralization assay
Description: In vitro measurement of neutralizing antibody activity to wild-type SARS-CoV-2
Study: NCT04035213

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavior of Sleep Course
Description: The current study will evaluate whether a semester-long course focused on sleep improves college students' sleep patterns over one semester compared to students completing a similar-level course in the same department (Psychology) at the same university.
Study: NCT03724487

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Coachman
Description: Coachman is comprised of: TBI and nurse counseling. TBI is comprised of: 1) web-based education modules on hypertension knowledge and skills as well as behavioral lifestyle guidance, (2) Medisafe, a smartphone medication management app to support medication adherence to antihypertensives, and (3) self-monitoring blood pressure. Participants will be exposed to nurse counseling, by registered nurses from the community, affiliated with a local nurse organization that will serve as community health workers (CHWs). The CHWs will provide informal counseling, social support, as well as follow-up phone sessions on medication adherence and monitoring blood pressure.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Usual Care (EUC)
Description: Standard printed education materials on hypertension management, including content on lifestyle modification and medication-taking will be provided; plus access to one web-based education (video) with information on how to self-monitoring blood pressure.
Study: NCT01945151

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group 2 (G2) NMES is applied in the spastic muscle (gastrocnemius).
Description: The G2 apply NMES in the gastrocnemius motor point and the rest will be done during stretching of the gastrocnemius muscle (autogenic inhibition). Five consecutive sessions will be held in the morning and afternoon in the laboratory of Sensory Motor Rehabilitation Engineering.
Study: NCT01559233

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FPlus RF device for wrinkles and rhytide reduction
Description: Six RF weekly treatments for face wrinkles and rhytides reduction using the FPlus device.
Study: NCT01519492

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AFN-12520000
Description: Two tablets taken in both the morning and evening on an empty stomach for a total daily dose 400 mg
Study: NCT01373931

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2216684
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2216684
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ortho Cyclen
Description: 35 micrograms (mcg) ethinyl estradiol and 250 mcg norgestimate administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ortho Cyclen
Description: 35 micrograms (mcg) ethinyl estradiol and 250 mcg norgestimate administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Administered orally
Study: NCT01720290

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: repaglinide
Description: Dose individually adjusted

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: repaglinide
Description: Dose individually adjusted

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: metformin
Description: Dose individually adjusted

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: metformin
Description: Dose at 1000 mg/day
Study: NCT01230255

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Percutaneous catheter drainage
Description: Ultrasound guided insertion of a 14 French pigtail catheter to drain free intra-peritoneal fluid or blood and thereby reduce elevated intra-abdominal pressure

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Percutaneous catheter drainage
Description: Ultrasound guided insertion of a 14 French pigtail catheter to drain free intra-peritoneal fluid or blood and thereby reduce elevated intra-abdominal pressure
Study: NCT02333214

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exergames and conventional physiotherapy
Description: The protocol of conventional physiotherapy will be customized and will include exercises to improve strength and muscle power, flexibility, mobility, balance, and aerobic conditioning exercises. In particular cases, when necessary analgesia will be used to relive pain. The progression of the exercises will be individualized according to the treatment plan established in the initial functional assessment and will be target to meet patient's improvement during treatment. Conventional physiotherapy will be conducted in pairs. In this group exercises that are best accomplished using virtual scenarios, such as dual task exercises, anticipatory adjustments exercises and inter limb coordination exercises will be performed using video games.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physiotherapy
Description: The protocol of conventional physiotherapy will be customized and will include exercises to improve strength and muscle power, flexibility, mobility, balance, and aerobic conditioning exercises. In particular cases, when necessary analgesia will be used to relive pain. The progression of the exercises will be individualized according to the treatment plan established in the initial functional assessment and will be target to meet patient's improvement during treatment. Conventional physiotherapy will be conducted in pairs. In this group dual task exercises, anticipatory adjustments exercises and inter limb coordination exercises will be performed without the virtual environment.
Study: NCT04467385

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VR training + Sensory Integration therapy + conventional therapy
Description: After the baseline assessment,~* Coconut ShootersVR - 5 min/day~* Ninja flipVR - 5 min/day.~* Sensory integration training include Exercises on BOSU ball and mini-trampoline. It will involve:~* Passive bouncing with child standing with his/her feet shoulder width apart for 2.5 and 2.5 minutes on both.~* Active bouncing (the child bounces and therapist will control the rate) for 2.5 and 2.5 minutes on both.~* Mini-squat exercises with feet apart and feet together for 2.5 and 2.5 minutes on both.~* Conventional exercises include:~  * passive stretching exercises for the hip flexors, hip adductors, hamstring, and calf muscle; stretching will be applied for 30 sec with 30 sec rest for each muscle group within pain limit.~ * Strengthening of abdominal and back muscles, hip abductions and knee joint extensors and ankle dorsiflexors will be performed.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VR training + conventional therapy
Description: After the baseline assessment,~* The Your Shape: Fitness Evolved 2012TM game is selected for VR training (walking and walking with obstacles) for 8 min~* Coconut ShootersVR - 8 min/day~* Ninja flipVR - 8 min/day~* Conventional Therapy - 20 min per day~  * Passive stretching exercises for the hip flexors, hip adductors, hamstring, and calf muscle; stretching will be applied for 30 sec with 30 sec rest 3-5 times for each muscle group within pain limit.~ * Strengthening of abdominal and back muscles, hip abductions and knee joint extensors and ankle dorsiflexors will be performed.
Study: NCT03001297

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive single dose of placebo matched MEDI5884 injection SC on Day 1

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MEDI5884 Dose 1
Description: Participants will receive single dose MEDI5884 Dose 1 injection SC on Day 1.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MEDI5884 Dose 2
Description: Participants will receive single dose MEDI5884 Dose 2 injection SC on Day 1

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MEDI5884 Dose 3
Description: Participants will receive single dose MEDI5884 Dose 3 injection SC on Day 1

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MEDI5884 Dose 4
Description: Participants will receive single dose MEDI5884 Dose 4 injection SC on Day 1
Study: NCT02514018

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Live-attenuated varicella-zoster virus vaccine
Description: Commercial vaccine used to prevent shingles

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Live-attenuated varicella-zoster virus vaccine
Description: Commercial vaccine used to prevent shingles
Study: NCT04023864

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Platycodon Grandiflorus Extract(GCWB107)
Description: Once-daily, once a tablet, after meals, for 12 week

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo for 12 week
Study: NCT04632602

Intervention type: OTHER
Group type: OTHER
Intervention: physiological effects of awake prone position in COVID 19 patients
Description: Study of physiological effects of awake prone position in COVID 19 patients on lung inhomogeneity assessed by Electrical Impedance Tomography (EIT), gas exchange and dyspnea score (Borg Scale).~Measurements will be performed at baseline (on supine position), then patients will be randomized on the order of position, either supine then prone, either prone then supine. Each period will last at least 2 hours. EIT records will be performed during the last 30 minutes of each period, blood gas and dyspnea score at the end of each period.

Intervention type: OTHER
Group type: OTHER
Intervention: physiological effects of awake prone position in COVID 19 patients
Description: Study of physiological effects of awake prone position in COVID 19 patients on lung inhomogeneity assessed by Electrical Impedance Tomography (EIT), gas exchange and dyspnea score (Borg Scale).~Measurements will be performed at baseline (on supine position), then patients will be randomized on the order of position, either supine then prone, either prone then supine. Each period will last at least 2 hours. EIT records will be performed during the last 30 minutes of each period, blood gas and dyspnea score at the end of each period.
Study: NCT01815788

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Use of a personal sound amplifying device = TeoFirst
Study: NCT04669730

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: usual care
Description: Routine care

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Walk
Description: Walk 30mins

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Baduanjin
Description: Baduanjin exercise is moderate in intensity and short in duration (a set of Baduanjin takes about 12 minutes). Baduanjin consists of the sitting and standing practicing form. The sitting Baduanjin exercise conforms to the aspects of low-intensity and long-term aerobic activity, which is suitable for the rehabilitation training of patients who are in stable condition during hospitalization. The standing Baduanjin is more suitable for patients with sequential rehabilitation after discharge and can be adjusted based on the patient's condition

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Baduanjin plus walk
Description: Walk 30mins then Baduanjin 12mins per day, 5 times per week.